What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Pulmonary hypertension
- Surgery
His primary areas of investigation include Pulmonary hypertension, Internal medicine, Cardiology, Anesthesia and Randomized controlled trial.
The Pulmonary hypertension study combines topics in areas such as Respiratory disease, Surgery, Endothelin receptor antagonist, Bosentan and Placebo.
He focuses mostly in the field of Internal medicine, narrowing it down to matters related to Endocrinology and, in some cases, RNA and TRPC6.
His Cardiac output study in the realm of Cardiology connects with subjects such as Task force.
His Anesthesia research is multidisciplinary, incorporating elements of Treprostinil, Hypoxia, Potassium channel and Selexipag.
His studies in Randomized controlled trial integrate themes in fields like Clinical trial and Combination therapy.
His most cited work include:
- Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) (3230 citations)
- Bosentan therapy for pulmonary arterial hypertension. (2301 citations)
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension (2191 citations)
What are the main themes of his work throughout his whole career to date?
Lewis J. Rubin mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Anesthesia and Surgery.
The various areas that Lewis J. Rubin examines in his Internal medicine study include Placebo and Endocrinology.
His Pulmonary hypertension research incorporates themes from Respiratory disease, Clinical trial, Randomized controlled trial, Intensive care medicine and Bosentan.
His Cardiology research is multidisciplinary, relying on both Blood pressure and Prostacyclin.
Lewis J. Rubin has included themes like Sildenafil, Adverse effect and Treprostinil in his Anesthesia study.
His research in Surgery intersects with topics in Gastroenterology and Ambrisentan.
He most often published in these fields:
- Internal medicine (62.10%)
- Pulmonary hypertension (52.42%)
- Cardiology (39.78%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (62.10%)
- Pulmonary hypertension (52.42%)
- Cardiology (39.78%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Pulmonary hypertension, Cardiology, Placebo and Randomized controlled trial.
His Internal medicine research focuses on subjects like Surgery, which are linked to Gastroenterology.
His studies deal with areas such as Anesthesia, Intensive care medicine, Bosentan, Ambrisentan and Disease as well as Pulmonary hypertension.
His work in Cardiology is not limited to one particular discipline; it also encompasses Quality of life.
His study looks at the relationship between Placebo and fields such as Riociguat, as well as how they intersect with chemical problems.
Prospective cohort study is closely connected to Clinical trial in his research, which is encompassed under the umbrella topic of Randomized controlled trial.
Between 2011 and 2021, his most popular works were:
- Macitentan and morbidity and mortality in pulmonary arterial hypertension. (827 citations)
- Riociguat for the Treatment of Pulmonary Arterial Hypertension (762 citations)
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension (551 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Lewis J. Rubin spends much of his time researching Pulmonary hypertension, Internal medicine, Surgery, Randomized controlled trial and Clinical endpoint.
His work carried out in the field of Pulmonary hypertension brings together such families of science as Anesthesia, Clinical trial, Placebo, Ambrisentan and Macitentan.
Many of his studies involve connections with topics such as Cardiology and Internal medicine.
His Hemodynamics and Riociguat study, which is part of a larger body of work in Cardiology, is frequently linked to World health, bridging the gap between disciplines.
The Proportional hazards model research Lewis J. Rubin does as part of his general Surgery study is frequently linked to other disciplines of science, such as Associated Pulmonary Arterial Hypertension, therefore creating a link between diverse domains of science.
His work in Randomized controlled trial tackles topics such as Selexipag which are related to areas like Multicenter study, Treatment outcome, Fatal disease and Familial primary pulmonary hypertension.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
